PD-L1 NEGATIVE

Clinical trials for PD-L1 NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new PD-L1 NEGATIVE trials appear

Sign up with your email to follow new studies for PD-L1 NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for tough breast cancer: combo therapy targets PD-L1-Negative tumors

Disease control Recruiting now

This study is for people with triple-negative breast cancer that has spread and does not have a protein called PD-L1. It compares a standard chemotherapy-like drug (sacituzumab govitecan) alone versus the same drug combined with an immunotherapy (pembrolizumab). The goal is to se…

Matched conditions: PD-L1 NEGATIVE

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated May 26, 2026 12:11 UTC

PD-L1 NEGATIVE

Get alerted when new PD-L1 NEGATIVE trials appear

New hope for tough breast cancer: combo therapy targets PD-L1-Negative tumors